HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Poulose, K. P. Articles by Goodyear, M. Search for Related Content PubMed PubMed Citation Articles by Poulose, K. P. Articles by Goodyear, M.

Cobalt-Labeled Bleomycin—A New Radiopharmaceutical for Tumor Localization. A Comparative Clinical Evaluation with Gallium Citrate

Washington Hospital Center and George Washington University, Washington, D.C.

Correspondence: For reprints contact: William C. Eckelman, Division of Nuclear Medicine, George Washington University Hospital, Washington, D.C. 20037.

ABSTRACT

The efficacy of ⁵⁷Co-labeled bleomycin as a tumor-scanning agent was evaluated in 50 patients with malignant tumor. In terms of sensitivity, labeled bleomycin was found to be a superior agent for malignant tumor detection when compared with ⁶⁷Ga-citrate (p 0.005). Maximum sensitivity (96%) was found in epidermoid carcinomas. Because of rapid blood clearance and rapid excretion by the kidneys, interpretation of ⁵⁷Co-bleomycin scans is facilitated.